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Quaternary ammonium compounds (QACs) are widely used in consumer products for 2 
disinfection purposes. QACs are frequently detected in aquatic systems at sub-3 
inhibitory concentrations and were found to affect the development of antimicrobial 4 
resistance if bacteria are exposed to increasing concentrations. However, the effect of 5 
a constant sub-inhibitory concentration on the development of bacterial resistance is 6 
unknown. A constant exposure to 88% of the minimum inhibitory concentration (MIC) 7 
of benzalkonium chloride (BAC) led to an increase of the MIC of P. aeruginosa. It 8 
increased from 80 mg l-1 to 150 mg l-1 after 10 cycles of exposure and remained stable 9 
after removal of BAC. When exposed to cetyltrimethyl ammonium chloride (CTMA), P. 10 
aeruginosa’s MIC increased from 110 mg l-1 to 160 mg l-1 after 10 cycles of exposure 11 
and decreased to 120 mg l-1 after removal of CTMA. Additionally, cross-resistance 12 
between the QACs was observed. When exposed to BAC, the MIC for CTMA 13 
increased from 110 mg l-1 to 200 mg l-1, and when exposed to CTMA, the MIC for BAC 14 
increased from 80 mg l-1 to 160 mg l-1. In contrast, the susceptibility to 16 antibiotics 15 
was not significantly affected by exposure to QACs. Finally, analyses of the 16 
membranes’ nanomechanical properties of P. aeruginosa with atomic force 17 
microscopy (AFM) showed increases in cell roughness, adhesion and stiffness after 18 
treatment with CTMA. Since sub-inhibitory concentrations of QACs can be detected in 19 
(technical) aquatic systems including sediments, this may lead to a dissemination of 20 




Quaternary ammonium compounds (QACs) are widely used disinfection agents in 23 
industrial, medical and household environments (1,2). Benzalkonium chloride (BAC, 24 
Figure 1A), a mixture of alkyl dimethyl benzylammonium chlorides, is among the most 25 
common QACs found in many consumer, industrial and medical products (3–5). 26 
Another widely used QAC is cetyltrimethyl ammonium chloride (CTMA; also known as 27 
cetrimonium chloride, Figure 1B). In the clinical context, high loads of QACs are used 28 
for the disinfection and cleaning of surfaces and medical instruments (6). The majority 29 
of the QACs is discharged to wastewaters (7–11), where they are further diluted and 30 
become micropollutants (12). QACs are known to have a poor biodegradability and to 31 
persist in waters (13–18). In hospital wastewaters, their concentrations have been 32 
measured in the mg l-1 range  (19–21), which is in the sub-inhibitory range for several 33 
bacteria such as Pseudomonas aeruginosa (P. aeruginosa) (19,20) In municipal 34 
wastewaters, where the dilution effect is bigger, concentrations were measured in the 35 
µg l-1 range (13,21). Concentrations of QACs in the ng l-1 to the µg l-1 have been 36 
detected in surface water [13], [19]. In soils and sediments, relatively high 37 
concentrations of QACs were also found, the sorption of QAC being high and also 38 
highly dependent on their structure (22). As desorption was also observed (22,23), 39 
local increases of concentrations of QACs are also possible in surface waters. 40 
Low concentrations of QACs can lead to a selection pressure on microorganisms’ 41 
populations, that may yield to more QAC-resistant populations (5,24). Bacterial 42 
populations have been known to adapt to sub-inhibitory concentrations by mechanisms 43 
such as modification of cell membrane structure, efflux pump expression and 44 
enhancement of biofilm formation (10,25). The mode of action of QACs at low 45 
concentrations may differ from the one at higher concentrations and may involve 46 
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multiple processes similar to antibiotics (10,26). Because of these similar mechanisms, 47 
cross-resistance towards other antibacterial agents can occur (20,27–29). Previous 48 
studies reported different results, either cross-resistance of P. aeruginosa to other 49 
disinfection agents and antibiotics or an absence of cross-resistance (28,30–35). The 50 
different results obtained in these previous studies highlight the need for more 51 
information on a potential development of cross-resistance.  52 
The level of resistance of bacteria or the potential for resistance development is linked 53 
with intrinsic properties of bacterial species (36). Among the different bacterial species, 54 
P. aeruginosa is known to be particularly resistant to QACs and to adapt easily to the 55 
presence of antibacterial agents (31). Moreover, P. aeruginosa is an important 56 
nosocomial bacterium, which is present in tap, recreational and surface water and has 57 
been involved in many infectious outbreaks (37–40). These characteristics make this 58 
species particularly suitable for investigating the effect of constant sub-inhibitory 59 
concentrations of QACs and other disinfection agents.   60 
QACs are part of commercial disinfection agents because of their antibacterial 61 
properties. QACs have been used for decades as active substances in commercial 62 
disinfection agents. Deconex® 53 PLUS, is a commercial product containing various 63 
disinfectants and a QAC (see below). Deconex® 53 PLUS is used for the pre-cleaning 64 
and disinfection of medical instruments. Other commercial disinfection agents include 65 
recently developed substances other than QACs. Incidin® PLUS, for example contains 66 
glucoprotamin as an active substance, which is included in several commonly used 67 
surface and instruments disinfection agents in the health care environment (41,42). A 68 
tetracycline-resistant strain of P. aeruginosa (PAO-LAC ATCC 47085) was found to be 69 
more resistant to this product than a non-antibiotic-resistant strain (42). However, no 70 
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studies were found on the potential of this product to promote resistance at sub-71 
inhibitory concentrations.   72 
To investigate the effects of QACs or other disinfection agents on bacteria, classical 73 
methods such as cultivation are commonly used. In addition to classical microbiological 74 
methods, atomic force microscopy (AFM) has been successfully applied to investigate 75 
and characterize the bacterial morphology related to resistance to antimicrobial 76 
compounds at a single-cell level (43–46). Measurements of alive bacteria in 77 
physiological conditions is possible with AFM, preventing any changes in the structure 78 
of the membrane when imaging the cells. The primary target of QACs is the bacterial 79 
membrane and changes in the membranes are suspected to be involved in the 80 
resistance mechanisms of P. aeruginosa to QACs. Therefore, AFM is likely to reveal 81 
potential changes in the membrane morphology as well as changes in the properties 82 
of the membrane in real-time (47). The aforementioned methods (classical 83 
microbiology and AFM) have been used to determine the effect of BAC exposure of 84 
bacteria. Other QACs, including CTMA, have been scarcely investigated. Studies on 85 
BAC focused on the development of resistance when exposed to increasing 86 
concentrations of the QAC, but the effect of a constant sub-inhibitory concentration of 87 
a QAC or glucoprotamin has had little attention (48).  88 
In this study, the consequences of an exposure of P. aeruginosa to BAC, CTMA, 89 
Deconex® 53 PLUS and to glucoprotamin were investigated. More specifically, the 90 
evolution of the MIC, cross-resistance with QACs and antibiotic susceptibilities 91 
following exposure were studied. Culture-based methods combined with AFM 92 
investigations were applied to characterize the properties of P. aeruginosa and 93 




Materials and Methods 96 
Bacterial strains 97 
Pseudomonas aeruginosa (ATCC® 27853™) was obtained from the ATCC collection. 98 
The strain was stored at -80°C using cryoinstant vials (VWR, Switzerland). Stock 99 
cultures were recovered from beads prior to each exposure experiment, by plating the 100 
beads on Lysogeny Broth Agar (LBA; Sigma-Aldrich, Switzerland) and on Columbia 101 
Blood Agar (Sigma-Aldrich, Switzerland). Colonies from these stock cultures were 102 
picked and dissolved in Mueller-Hinton broth (MHB; Sigma-Aldrich, Switzerland) to 103 
prepare overnight cultures. Overnight cultures were prepared by incubating the tubes 104 
at 37°C and 220 rpm for 12 to 18 hours. 105 
Disinfection agents 106 
The disinfection agents used in this study were two QACs, benzalkonium chloride 107 
(BAC, CAS 63449-2) and cetyltrimethyl ammonium chloride (CTMA, CAS 112-02-7) 108 
and two one commercial products, Deconex® 53 PLUS and Incidin® PLUS. BAC 109 
(Sigma-Aldrich, Switzerland) was composed of 70% benzyldimethyldodecyl 110 
ammonium chloride and 30% benzyldimethyltetradecyl ammonium chloride. The 111 
concentration of the product was ≥ 95% and was of the highest purity available. CTMA 112 
(Sigma-Aldrich, Switzerland) had a concentration of 25 wt. % in H2O with the highest 113 
purity available. Deconex® 53 PLUS (Ecolab Helathcare, Switzerland) contains 9.4% 114 
of the active substances (3.8 g alkyl propylene diamine guanidinium diacetate and 5.6 115 
g N,N-didecyl-N-methyl-poly(oxyethyl)ammonium propionate per 100g of product). 116 
Incidin® PLUS (Ecolab Healthcare, Switzerland) contained 26% of glucoprotamin as 117 
the active substance. Stock solutions of 10,000 mg l-1 of the different antibacterial 118 
agents were prepared in Mueller Hinton Broth (MHB). The MHB was sterilized by 119 
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autoclaving before the addition of the QACs or the disinfection agents and the stock 120 
solution (MHB and disinfection agent) was filtered by 0.2 µm filters (Filtropur S 0.2S; 121 
Sarstedt, Switzerland). The filter-sterilized solutions were then further diluted with in 122 
autoclaved MHB to the concentrations of interest for the experiments (MIC 123 
determination and repeated exposure). The stock solutions were kept at room 124 
temperature and used within a week.  125 
Determination of MICs 126 
MICs were determined with broth microdilutions following the protocol by Wiegand et 127 
al. (2008) (49). Bacterial suspensions were prepared by overnight culture, two to three 128 
colonies were diluted in 10 ml of autoclaved MHB and incubated during 12 to 18 hours 129 
at 37°C and 220 rpm. The overnight cultures were diluted to achieve an optical density 130 
of 0.12 at 600 nm (OD600) with an optical path length of 1 cm, which was determined 131 
to correspond to a concentration of (1-2) x 108 CFU ml-1 (colony forming units per ml).  132 
This solution was then diluted 1:100 to reach a final concentration of (1-2) x 106 CFU 133 
ml-1. 134 
The 10 first rows of a sterile 96-well microplate (Nunclon™ Delta Surface, Thermo 135 
Scientific, Switzerland) were filled with 50 µl of increasing concentrations of 136 
antibacterial solutions. The eleventh column was filled with 50 µl of MHB and 50 µl of 137 
bacterial suspension (growth control) and the twelfth with 100 µl of a sterile control. 138 
Each well of the antibacterial testing and the growth control were inoculated with 50 µl 139 
of the bacterial suspension. The microplate was incubated at 37°C for 16-20 hours. 140 
The concentrations used for the MIC determination are available in the Supporting 141 
Information (Table S1, ESI). After incubation, growth was assessed by turbidity or 142 
sediments in the wells. The MIC is defined as the lowest concentration of the 143 
antibacterial agent that inhibits visible growth (49,50).  144 
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Repeated exposure to a sub-inhibitory concentration of a disinfection agent  145 
Figure 2 summarizes the exposure experiments carried out with P. aeruginosa. Tubes 146 
containing 10 ml of sub-inhibitory concentrations of BAC, CTMA, Deconex® 53 PLUS 147 
or Incidin® PLUS were inoculated with 100 µl of an overnight culture of P. aeruginosa 148 
diluted to obtain a final concentration of 106 CFU ml-1 in the tube at the beginning of 149 
the cycle. Concentrations of CTMA and BAC were set at 86 and 88% of the MIC, at 150 
87% of the MIC for Deconex® 53 PLUS and at 88% of MIC for Incidin® PLUS, to remain 151 
in the sub-inhibitory range while still having a high selective pressure. For BAC, an 152 
additional exposure concentration of 50% of the MIC was tested. For the QACs, one 153 
exposure cycle consisted of a 48 hours’ incubation at 37°C and 220 rpm. After 48 154 
hours, the MIC was determined and the bacterial suspension was used to inoculate a 155 
new series of tubes with the same sub-inhibitory concentration. A purity check was 156 
added by plating 50 µl of the bacterial suspension on plate count agar (PCA; Sigma-157 
Aldrich, Switzerland). This was repeated to reach 10 cycles. Samples were 158 
cryopreserved using cryoinstant vials after 5 and 10 cycles of exposure. Two controls 159 
were added, one by cycling the bacteria in absence of the disinfection agent in the 160 
growth medium (MHB) and a negative control with the growth medium only. A slightly 161 
different protocol was used for the exposure to Deconex® 53 PLUS and to Incidin® 162 
PLUS, one exposure cycle was defined as 24 hours and the total experiment lasted 10 163 
cycles of exposure for Deconex® 53 PLUS and 15 for Incidin® PLUS 15 cycles of 164 
exposure followed by 5 cycles of stability. The MICs were determined every five cycles 165 
of exposure and the samples were cryopreserved at the same time.  166 
Stability  167 
To investigate if the effects of the exposure to disinfection agents remains stable in 168 
absence of the disinfection agent from the medium, five cycles in disinfection agent-169 
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free MHB were added at the end of the total exposure (10 cycles). As in the exposure 170 
experiments, cycles of 48 h were carried out and a purity check was added after each 171 
cycle. The MIC was determined after each cycle, the antibiotic susceptibility profile and 172 
the cross-resistance was assessed at the end of the three cycles. For Deconex® 53 173 
PLUS and Incidin® PLUS, cycles of 24 h were added for the stability experiments.  174 
Determination of the antibiotic susceptibility profiles 175 
10 antibiotics, which are known to be effective against P. aeruginosa, were selected 176 
according to the European Committee on Antimicrobial Susceptibility Testing 177 
(EUCAST) recommendations (51). The selected antibiotics belong to the classes of 178 
aminoglycosides (tobramycin 10 µg; amikacin 30 µg; gentamycin 10 µg), 179 
cephalosporin (cefepime 30 µg; ceftazidime 10 µg), fluoroquinolones (ciprofloxacin 5 180 
µg; levofloxacin 5 µg); penicillin (piperacillin-tazobactam 36 µg) and carbapenem 181 
(imipenem 10 µg; meropenem 10 µg). In addition, 6 antibiotics, to which P. aeruginosa 182 
is naturally resistant, were also tested. These antibiotics belong to the classes of 183 
cephalosporin (cefoxitine 30 µg; cefuroxime 30 µg), penicillin (ampicillin 10 µg), 184 
sulfonamide (co-trimoxazole 25 µg), nitrofuran (nitrofurantroin 100 µg) and tetracycline 185 
(minocycline 10 µg). They were used in the form of antimicrobial susceptibility disks 186 
(Thermo Scientific™ Oxoid™ Gentamycin Antimicrobial Susceptibility Disks, Thermo 187 
Scientific, Switzerland). The disks were stored at -20°C, according to the 188 
manufacturer’s instructions.  189 
The antibiotic susceptibility profiles were determined using the disc diffusion method 190 
after 5 and 10 cycles of exposure, following the EUCAST methodology (51). The 191 
bacterial growth was diluted in MHB to reach an OD600 of 0.12, as in the determination 192 
of the MIC. This solution was swabbed on Mueller-Hinton agar plates (MHA plates). 193 
Antibiotic discs were then applied to the agar surface using a disc dispenser (Oxoid™ 194 
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Antimicrobial Susceptibility Disk Dispenser) and the plates were incubated for 24 hours 195 
at 37°C. The inhibition zone diameters (IZD) were recorded using calipers after the 196 
incubation period. The IZDs were then compared to the EUCAST database for P. 197 
aeruginosa (51). 198 
Cross-resistances among QACs 199 
Susceptibility to the QAC to which the bacterial populations were not exposed was 200 
determined to investigate if exposure to one QAC leads to a higher resistance to the 201 
other one. The MIC for CTMA was determined after 5 and 10 cycles of exposure to 202 
BAC and after the stability period using the broth microdilution method. The MIC for 203 
BAC was determined after 5 and 10 cycles of exposure to CTMA and after the stability 204 
period using the broth microdilution method. 205 
AFM Imaging 206 
AFM measurement were performed on the treated cells with approximately 90% of the 207 
MIC during 10 cycles (for CTMA and BAC only). The measurements were performed 208 
before the stability period but in absence of the QACs. The bio-mechanical properties 209 
of P. aeruginosa strains were measured using a JPK NanoWizard 3 AFM (Bruker Nano 210 
GmbH, Germany), equipped with a Zeiss TE-100 inverted microscope (Bruker, 211 
Germany) in PBS buffer at room temperature (25 °C). The so called “quantitative 212 
imaging” mode was used to image the cells to gather both high quality 3D topology 213 
and determine mechanical properties, adhesion and stiffness. The scan size of the 214 
AFM images was adapted to fit an area with at least 20 cells and 10 areas per samples 215 
have been imaged. Typically, a square ranging from 15x15 to 25x25 µm was chosen. 216 
Every image consisted of either a 64×64 or a 128×128 force-distance (F/d) curve 217 
recorded with an indentation dwell-time of 80 milliseconds and a set-point force of 1200 218 
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pN. Specifically, each pixel in the AFM adhesion image has a value of force that is 219 
basically the registered minimum in the retrace function of the F/d curve. The adhesion 220 
force is a minimum value because it is considered as a pulling force from the cell 221 
towards the cantilever, and thus generated from the cell. For these experiments we 222 
used 200 µm -long triangular silicon nitride probes, supplied by pyramidal tips with a 223 
nominal radius of 20 nm (DNP-10 Bruker, Bruker Nano Inc., CA, USA) and a nominal 224 
spring constant of 0.06 N/m. The scanned height was set to 1 µm, to be able to 225 
completely cover the cell height. The bottom glass-modified petri dishes, employed for 226 
the AFM experiments, allowed us to strongly improve the stiffness image contrast, due 227 
to few orders of magnitude differences between cells (hundreds of kPa) and glass 228 
(hundreds of MPa) Young’s modulus. 229 
AFM Data Processing 230 
The AFM data were processed using the “JPK Data Processing” software to obtain the 231 
values for the adhesion parameters and by applying the Hertz-Sneddon fit it calculates 232 
the Young’s modulus. A Matlab (MathWorks Inc., CA, USA) script, developed in our 233 
laboratory allowed to sharply discriminate and extract the points belonging to the 234 
bacteria cells from the background and then use them to plot the final graphs. Briefly, 235 
the script analyses each stiffness, adhesion and height image files and it creates a new 236 
matrix text file (64×64 or 128×128 points, based on the original image size) made of 0 237 
and 1, where 0 means background and 1 means cell. The selection process consists 238 
of applying a threshold on the height AFM image. The so generated matrix files are 239 
then plotted as black and white images to check whether the script worked correctly. 240 
Afterwards the matrix files are used as a mask to extract the positive matching points 241 
from the stiffness, adhesion and height files. The selected points are finally plotted and 242 
averaged using the software OriginPro 2018 (OriginLab Corporation, MA, USA).  243 
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The average roughness was calculated by the “JPK Data Processing” software, which 244 
can calculate the average roughness (here named also Ra) of a specifically selected 245 
cross section from the raw files. 246 
Statistical analyses 247 
1. MIC evolution upon exposure to disinfection agents 248 
To determine the statistical significance of the results for the evolution of the MIC 249 
during exposure to sub-inhibitory QAC concentrations, linear regression analysis was 250 
used. The analyses were performed in R using the R package lme4 (52). To test if the 251 
MIC significantly changes over the cycles when exposed to a disinfection agent, 252 
measurements taken during the stability period were excluded and a linear regression 253 
was performed. The variables of the mixed model were selected using a backward 254 
approach; a reduced model missing the variable of interest was compared to the full 255 
model by an ANOVA. The p-value was extracted and the variable was considered as 256 
having a significant effect on the MIC for p-values < 0.01. 257 
2. Stability period and cross-resistance 258 
To determine the statistical significance of the stability period, dependent t-tests were 259 
performed. MIC at the end of the exposure period (after 10 cycles) were compared to 260 
values after the three cycles of stability. If significant differences were observed (p-261 
value < 0.01), the MIC after stabilization was compared to the MIC before exposure to 262 
assess if the MIC was reversible.   263 
The significance of the cross-resistance values was investigated using dependent and 264 
independent t-tests. MICs for one disinfection agent were compared at similar time 265 
points after exposure to both disinfection agents and to the control. Differences were 266 
considered significant for p-values < 0.01. 267 
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3. Antibiotic susceptibilities 268 
The effects of the exposure to disinfection agents on antibiotic susceptibilities were 269 
analyzed using ANOVA on three populations (exposed to CTMA, exposed to BAC and 270 
not exposed) after 5 and 10 cycles of exposure and after the stability period. False 271 
discovery rate adjustment (Bonferroni) (53) was applied to correct the p-values. For 272 
the antibiotics for which the difference was still significant after correction (p-value < 273 
0.01), Tukey’s HSD was applied to determine for which pairs the difference was 274 
significant. The results were then compared to the EUCAST threshold values for 275 
resistance (51).  276 
4. AFM data 277 
The effect of the exposure to disinfection agents on the bacterial mechanical properties 278 
was analyzed using a one-tail ANOVA on the three populations (exposed to CTMA, 279 
exposed to BAC and not exposed). The p-value was considered significant if < 0.05. 280 
To assess the roughness property difference, a non-parametric Mann-Whitney test 281 
was applied with a p-value < 0.05. 282 
 283 
Results  284 
1.1. Evolution of the MIC of P. aeruginosa for CTMA and BAC with exposure 285 
cycles and stability after removal of the disinfection agent 286 
CTMA 287 
The MIC of P. aeruginosa for CTMA was determined by broth microdilutions to be 110 288 
mg l-1. Based on this result, the sub-inhibitory concentration to which the bacterial 289 
populations were exposed was set at 95 mg l-1 (86% of MIC). This concentration is in 290 
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the sub-inhibitory range but will also exert a mild selective pressure (24). For P. 291 
aeruginosa exposed to this sub-inhibitory concentration of CTMA a significant increase 292 
of the MIC was observed. Each cycle contributed significantly (p<0.001) to an average 293 
increase of the MIC between 5.0 ± 0.8 mg l-1 (replicate 1), 3.6 ± 0.9 mg l-1 (replicate 3) 294 
and 2.7 ± 0.7 mg l-1 (replicate 2). After 10 cycles, the MIC reached a value of 150 ± 10 295 
mg l-1 (Figure 3A). Overall the MIC increased by a factor of 1.3 - 1.45. In the control 296 
experiment (cycling without exposure), no significant changes in the MICs were found 297 
(Table S1, ESI). 298 
The stability of the adaptation to CTMA was tested by five additional cycles in absence 299 
of CTMA. The MIC was again tested at the end of these cycles and a significantly lower 300 
value was found. However, the MIC after this procedure was still significantly higher 301 
(127.5 ± 9.6 mg l-1) than the initial value. The values were at an intermediate level 302 
between samples that were non-exposed and exposed to CTMA for 10 cycles (Figure 303 
3A, Table S2, ESI).  304 
BAC 305 
The MIC of P. aeruginosa for BAC was determined to be 80 mg l-1. 306 
P. aeruginosa was exposed to 40 mg l-1 BAC, which corresponds to 50% of the MIC 307 
(Figure S1, ESI). The effect of exposure on the MIC of the strains was significant but 308 
small for replicate 1, where an average increase of the MIC of 1.36 ± 0.45 mg l-1 per 309 
cycle was observed. The effect of the cycles was not significant and no increase was 310 
observed for replicates 2 and 3. After removal of the BAC from the medium, the small 311 
increase observed after 10 cycles is no more present and the MIC is back towards the 312 
initial value. 313 
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To induce a potentially larger effect, P. aeruginosa was exposed to a concentration 314 
equal to 88% of the MIC (70 mg l-1). When exposed to this concentration of BAC, the 315 
MIC increased first to 125 mg l-1 and then to 150 mg l-1 (replicates 1 and 2). For 316 
replicate 3, the MIC increased to 100 mg l-1. Thus, the final observed increase factors 317 
were 1.9 (replicates 1 and 2) and 1.25 times the initial MIC (replicate 3, Figure 3B, 318 
Table S2, ESI). 319 
The stability of the adaptation to BAC was tested by five additional cycles in absence 320 
of BAC. The MIC was again measured after these cycles and the value obtained was 321 
similar to the one obtained at the end of the exposure period. Therefore, the MIC values 322 
remained at 150 mg l-1 (replicates 1 and 2) and a small decrease was observed for 323 
replicate 3, with a MIC at 90 mg l-1 after the stability period.  324 
1.2. Cross-resistance between the QACs 325 
Cross-resistance between the QACs was assessed by testing the populations for 5 326 
and 10 cycles of exposure to BAC followed by 5 cycles of stability against CTMA and 327 
the CTMA-exposed population against BAC. The results are provided in Table S3 (ESI) 328 
and in Figures 5A and B. A weak positive correlation was also found between the 329 
increase of the MIC for BAC and the increase of the MIC for CTMA when exposed to 330 
BAC (Spearman correlation factor of 0.6) (Figure 5A). A stronger positive correlation 331 
between the increase of the MIC for exposure to CTMA and the increase of the MIC 332 
for BAC when pre-exposed to CTMA was found (Spearman correlation factor of 0.8) 333 
(Figure 5B).  334 
1.3. Antibiotic susceptibilities after exposure to QACs  335 
The effects of the exposure of P. aeruginosa to sub-inhibitory QAC concentrations after 336 
5 and 10 cycles on the antibiotic susceptibilities was tested using an analysis of 337 
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variance between the control and the exposed populations followed by a Dunnett post-338 
hoc test (Table S4, ESI). From the results of the statistical analyses, after 10 cycles of 339 
exposure, significant differences (p<0.01) were observed for amikacin, tobramycin, 340 
gentamycin (higher resistance of P. aeruginosa), and piperacillin-tazobactam (lower 341 
resistance of P. aeruginosa) for the strain exposed to CTMA versus the control. 342 
Bacteria exposed to BAC exhibited statistical differences for levofloxacin, imipenem 343 
and minocycline (lower resistance of P. aeruginosa) after 10 cycles of exposure. 344 
However, the difference in resistance observed with these antibiotics was insufficient 345 
to modify the categorical interpretation (Susceptible /Intermediate /Resistant) 346 
according to EUCAST breakpoints. Among the 16 antibiotics tested, P. aeruginosa is 347 
intrinsically resistant to six of them and being exposed to either BAC or CTMA did not 348 
affect this intrinsic resistance. 349 
1.4. Evolution of the MIC of P. aeruginosa for Deconex® 53 PLUS with 350 
exposure cycles and stability after removal of the disinfection agent 351 
Figure 4 shows the evolution of the MIC of P. aeruginosa for exposure to 140 mg l-1 of 352 
Deconex® 53 PLUS (13 mg l-1 active substance), which corresponds to 87% of the MIC 353 
(160 mg l-1, 15 mg l-1 of active substance). The MIC increased to 300 mg l-1 (28 mg l-1 354 
of active substance) for one replicate (replicate 1) and to 266 mg l-1 (25 mg l-1) for two 355 
replicates (replicates 2 and 3). Each cycle contributed to an increase of the MIC by an 356 
average of 10 mg l-1, independently of the replicate. The control remained at 168±20 357 
mg l-1 (16±1.8 mg l-1 active substances). After a stability period of 5 cycles in absence 358 
of the disinfection agents, the MIC either stayed at the higher value (replicates 1 and 359 
3) or decreased to 212 mg l-1 (replicate 2).  360 
An exposure to Deconex® 53 PLUS also led to a decreased susceptibility to both CTMA 361 
and BAC (Figures 5C and D). When exposed to Deconex® 53 PLUS, the MIC for CTMA 362 
16 
 
increased to 250 mg l-1, 2.25 times the initial MIC, for replicate 1, and to 200 mg l-1 , 363 
1.8 times the initial MIC, for replicates 2 and 3 (Figure 5C). The MIC for BAC increased 364 
to 140 mg l-1, 1.75 times the initial MIC for replicate 1 and to 100 mg l-1, 1.25 times the 365 
initial MIC, for replicates 2 and 3 (Figure 5D).   366 
The increase in the MIC was strongly correlated with increases in the MIC for BAC and 367 
CTMA with Spearman correlation factors of 0.94 (for CTMA) and 0.84 (for BAC). 368 
1.5. Evolution of the MIC of P. aeruginosa for Incidin® PLUS with exposure 369 
cycles and stability after removal of the disinfection agent 370 
Exposure to Incidin® PLUS during 15 cycles of 24 hours led to a significant increase of 371 
the MIC of P. aeruginosa The MIC was determined to be 40 mg l-1 (10 mg l-1 of 372 
glucoprotamin) prior to exposure. The concentration of exposure was set at 35 mg l-1 373 
(9 mg l-1 glucoprotamin; 88% of the MIC). The MIC reached a maximum of 100 mg l-1 374 
(26 mg l-1 glucoprotamin) after 15 cycles of exposure (Figure 4B, replicate 3), which 375 
correspond to an increase of the initial MIC by a factor of 2.5 and each cycle increased 376 
the MIC by an average of 3.2 ± 1.2 mg l-1. An increase to 70 mg l-1 (18 mg l-1 377 
glucoprotamin) was observed for replicate 3, which corresponds to an increase of the 378 
initial MIC by a factor 1.75 and an increase per cycle of 1.73 ± 0.5 mg l-1. The control 379 
(not exposed to Incidin® PLUS) remained at 40 mg l-1 (10 mg l-1 glucoprotamin) during 380 
the cycling period (Figure 4B).  381 
The stability of the adaptation to Incidin® PLUS was investigated by removing the 382 
disinfection agent from the growth media during 5 cycles (in this case, of 24 hours). 383 
The increases in the MICs were stable and irreversible, remaining at the values 384 
obtained at the end of the exposure period.   385 
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1.6. Antibiotic susceptibilities following exposure to Deconex® 53 PLUS and 386 
Incidin® PLUS 387 
The effects of exposure to sub-inhibitory concentrations of Deconex® 53 PLUS and of 388 
Incidin® PLUS concentrations after 5, 10 and 15 cycles on the antibiotic susceptibilities 389 
was tested using an analysis of variance between the control and the exposed 390 
populations followed by a Dunnett post-hoc test, similarly to QACs. No differences 391 
were observed between the Incidin® PLUS exposed strains and the controls  (data not 392 
shown). 393 
1.7. AFM 394 
The AFM measurements allowed to investigate the mechanical properties of single P. 395 
aeruginosa cells at the nanometric scale. The main properties that were elucidated by 396 
this method are: (1) The roughness of the bacterial outer membrane, (2) the stiffness 397 
of the whole bacteria cell and (3) its adhesion properties. The AFM probe (also named 398 
cantilever tip) having a diameter of roughly 40 nm, is able to detect and scan very small 399 
details of the bacterial surface. The P. aeruginosa cells showed an average roughness 400 
(Ra) of 30nm (Figure 6A - left) when no QAC exposure occurred. CTMA treatment 401 
strongly affected the outer membrane characteristics of P. aeruginosa. The measured 402 
Ra after exposure to CTMA was around 95nm, on average, with peaks of 200 nm 403 
(Figure 6A – right). When BAC was administered, the average measured Ra was 404 
around 75 nm (Figure 6A – middle). Hence, for both tested QACs the outer membrane 405 
roughness significantly changed as a consequence of the positive charge interactions 406 
with the membrane components.  407 
Furthermore, the probe indentation on the bacterial cell allowed to obtain a precise 408 
measurement of cell stiffness. In addition, the recording of any occurring interaction 409 
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event, of either weak or strong value in between the tip and the protein/lipid matrix of 410 
the outer membrane, allowed to obtain roughness and adhesion parameters. Even 411 
though, the cantilever tip was not functionalized with any biological molecule (for 412 
instance: fibronectin, collagen, concanavalin-A, antibodies, etc.) and the indentation 413 
contact time was less than 100ms, a measurable interaction still remained with an 414 
adhesion peaks plotted in Figure 6B. In Figures 6B and C, each point corresponds to 415 
a pixel belonging to the whole bacteria population that has been imaged with the AFM 416 
(almost 100 cells per treatment in at least 5 different images of 20 µm × 20 µm, with a 417 
resolution of 128x128 pixels). For P. aeruginosa, the registered average value of 418 
adhesion was almost 1.0 nN, whereas after the treatment with BAC it dropped to less 419 
than the half, specifically 0.4 nN (Figure 6B). Interestingly, the treatment of P. 420 
aeruginosa with CTMA increased the adhesion properties between the outer 421 
membrane and the cantilever tip by almost 50% compared to the original strain, 422 
yielding an average value of 1.5 nN. When the adhesion properties after BAC treatment 423 
is compared with the CTMA treatment a statistically significant difference (one-tail 424 
ANOVA, p-value < 0.05) of more than 3-fold was found, 0.4 versus 1.5 nN, respectively.  425 
In Figure 6C the Young’s modulus values distribution is plotted as a parameter to 426 
represent the bacterial stiffness. The measured stiffness from the three bacteria 427 
populations differed significantly only for the CTMA treated case. The determined value 428 
for the investigate P. aeruginosa strain (ATCC 27853) is around 210 kPa, which is the 429 
same as for the BAC-treated case (almost 210 kPa). Remarkably, CTMA acted 430 
differently again from the BAC counterpart by significantly increasing the bacteria 431 






2.1. Evolution of the MIC of P. aeruginosa for CTMA and BAC with exposure 436 
cycles, stability after removal of the disinfection agent and cross-437 
resistances between the QACs and with antibiotics 438 
Populations of P. aeruginosa were exposed to constant sub-inhibitory concentrations 439 
of CTMA and BAC, and adaptation occurred (increase in MIC) when the bacteria were 440 
exposed to a concentration of the selected QACs corresponding to approximately 90% 441 
of the MIC. A small increase in the MIC was observed for one replicate (out of three) 442 
when P. aeruginosa was exposed to 50% of the MIC. The strength of the selection 443 
pressure was important, as in the case of BAC, the adaptation was much stronger with 444 
an exposure concentration at 90% of the MIC compared to an exposure concentration 445 
of 50% of the MIC. However, it cannot be excluded that stronger adaptation may occur 446 
for longer exposure periods with < 90% of the MIC. When exposed to approximately 447 
90% of the MIC of the selected QACs, the general trend was an increase of the MIC, 448 
however, the individual replicates showed different patterns. Previous studies revealed 449 
that a long-term exposure to BAC led to a reduction in the community diversity and an 450 
increase in the resistant bacteria (25,54). Variability in the adaptation was also 451 
observed here, resulting from a low selective pressure. This variability can be the result 452 
of either different mechanisms or differences in the speed of adaptation. Exposure of 453 
E. coli strains to sub-inhibitory concentrations of BAC led to different phenotypical 454 
variants (25) and it is possible that the resulting exposed populations in this study are 455 
also comprised of phenotypic variants.   456 
The results showed that an increase was still present at the end of the 10 cycles 457 
investigated (Figures 3 and 5). In previous studies it has been shown that an increasing 458 
concentration of QACs ultimately reaches a plateau of the MIC (35). It can be 459 
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hypothesized that an exposure to a constant sub-inhibitory concentration of QACs also 460 
ultimately leads to a plateau of the MIC.  461 
After removal of the QAC from the growth medium, the MIC for CTMA decreased to 462 
similar values prior to the exposure. However, when exposed to BAC, the MIC reached 463 
during the exposure period remained stable at the higher level. If the mechanisms are 464 
of similar nature, as shown with the experiments on cross-resistance, exposure to 465 
CTMA seems to trigger a transient mechanism of adaptation, which is different from 466 
BAC. Mechanisms of adaptation or resistance to QACs includes modification of the 467 
membrane or expression of efflux pumps (29,33,54). These mechanisms are 468 
consistent with a transient change either in the structure of the membrane or in the 469 
level of expression of other resistance mechanisms. The differences observed 470 
between the two selected QACs might be linked to the composition of the QACs, BAC 471 
being a mixture of several quaternary ammonium compounds with different aliphatic 472 
chains ranging from 8 to 16 carbon atoms with an aromatic ring (Figure 1A), while 473 
CTMA is a single quaternary ammonium compound with one aliphatic chain length 474 
(Figure 1B). However, this would need further investigations.  475 
When exposed to CTMA first, P. aeruginosa became more resistant to BAC and when 476 
exposed to BAC, it became more resistant to CTMA (Figures 5 A and B,). This result 477 
was demonstrated by a positive correlation score obtained in both cases. This might 478 
mean that the mechanisms involved are shared or similar for the two QACs. The nature 479 
of the mechanism might rather be the result of phenotypical changes for CTMA, 480 
because the increase of the MIC after removal of the QAC was reversible. For the other 481 
tested compounds, genotypic changes cannot be excluded. The increased resistance 482 
might be linked to morphological changes of the membrane observed by AFM or to the 483 
expression of other mechanisms, such as efflux pumps as shown in previous studies 484 
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(29).  When exposed to a commercial disinfection agent containing QACs, cross-485 
resistance was also observed with BAC and CTMA. Strains exposed to Deconex® 53 486 
PLUS demonstrated a higher tolerance for CTMA and BAC compared to their control. 487 
Similarly, to BAC and CTMA only, the degree of tolerance was strongly correlated with 488 
the level of adaptation. The decrease in the susceptibility, when exposed to Deconex® 489 
53 PLUS, was stronger for CTMA, for which a maximum increase in the MIC of up to 490 
a factor 1.25 was observed (Figure 5C). For BAC, it reached a maximum increase of 491 
the MIC by a factor 1.8 (Figure 5D).  492 
Cross-resistance with antibiotics was less evident than for QACs. Statistical 493 
differences were observed with either increased or decreased resistance to antibiotics. 494 
However, the categorical interpretation (S/I/R) according to EUCAST breakpoints were 495 
not modified. These results are in accordance with previous studies, in which exposure 496 
to BAC or CTMA did not lead to any significant difference in the resistance profile to 497 
antibiotics (30–32).  498 
2.2. Morphological evolution of the bacteria 499 
AFM investigations revealed some differences in the treated compared the non-treated 500 
bacterial cells. The roughness of the cells increased with the treatment, similarly to the 501 
results of other studies investigating antibiotics or antimicrobial agents (46,55,56). As 502 
QACs are agents targeting the outer membrane of bacteria, this result indicates that 503 
even at subinhibitory concentrations, bacterial membranes are affected by QACs. The 504 
mechanism of action of QACs is known to be an association of the positively charged 505 
quaternary nitrogen with the head groups of acidic-phospholipids of the membrane 506 
(57). This interaction decreases the fluidity of the membrane at concentrations close 507 
to the MIC (57). Adaptation of P. aeruginosa to one QAC was observed to result in 508 
changes in the cell surface hydrophobicity and biofilm formation, but also to be the 509 
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cause of changes in the outer membrane proteins and the permeability (31,33). When 510 
exposed to CTMA, the stiffness of the cells increased by a factor of 3 (Figure 6C), 511 
leading to more rigid cells compared to the control, which is consistent with the 512 
expected mode of action of QACs. This was not the case for the cells exposed to BAC, 513 
as such an increase in the Young modulus was not observed. 514 
Interestingly, the bacterial surface adhesion properties, measured as the pulling force 515 
exerted by the membrane matrix towards an uncoated-silicon probe, revealed a strong 516 
decrease when the bacteria were treated with BAC, whereas in the case of CTMA an 517 
increase in the unspecific adhesion properties was registered (Figure 6B). Adhesion 518 
properties of a bacterial cell are also linked with their ability to create biofilms (58). P. 519 
aeruginosa is known to form biofilms and to use biofilms as a defense against different 520 
chemicals. It was previously observed that BAC inhibits the biofilm formation of P. 521 
aeruginosa, which could explain the observed decrease in the adhesion properties 522 
when exposed to BAC (59). In contrast, in this study, the adaptation of P. aeruginosa 523 
to CTMA was associated with modifications of the bacterial membrane and an increase 524 
in adhesion properties, which could enhance the biofilm formation. These two 525 
mechanisms are consistent with previous observations when increasing 526 
concentrations of QACs were used, either with biofilm as a resistance mechanism (60) 527 
or with an exposure to BAC preventing the biofilm formation  (59). 528 
Even though CTMA and BAC modified the biomechanical properties of P. aeruginosa 529 
in a significantly different way, they both strongly affect the cells by modifying their 530 
morphological properties and hence the bacterial interaction with the external 531 
environment. Besides, the outer membrane roughness significantly changed by 532 
increasing the numbers and the height of “hills” and “valleys” of the external lipid bilayer 533 
and the lipo-poly-saccharides matrix. Potentially, the measured roughness could be a 534 
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consequence of a deeper and stronger modification at a lower membrane level, mainly 535 
affecting the inner membrane.  536 
2.3. Practical implications: exposure to commercial disinfection agents 537 
Two commercial disinfection agents, currently used in the health care context for 538 
medical instrument pre-cleaning/disinfection and surface cleaning detergent were 539 
tested to compare their effects with single compounds (BAC and CTMA). Exposure to 540 
both disinfection agents, in their commercial forms, led to an adaptation of the exposed 541 
populations. The increase of the MIC, after 10 cycles, was similar for both products, 542 
an average factor of 1.7 for Deconex® 53 PLUS and 1.75 for Incidin® PLUS. Both 543 
commercial products led to adapted populations of P. aeruginosa similarly to QACs. 544 
The adaptation is stable during the 5 cycles in absence of the product, which is similar 545 
to BAC but different to CTMA. Exposure to QAC-containing commercial products also 546 
yielded an increased tolerance to the two pure QACs tested, but no changes in the 547 
antibiotic resistances. 548 
This result is relevant for cases where bacterial populations are in contact with residual 549 
concentrations of the product. Due to a widespread application of QACs in hospitals, 550 
some uses in cleaning and discharge of wastewaters or other point sources may 551 
contain relatively high sub-inhibitory concentrations of disinfection agents, which may 552 
lead to development of increased MICs in the bacterial communities. Depending on 553 
the applied QAC-containing disinfection agents, it may also lead to morphological 554 
changes and adhesion and biofilm formation potentials. In contrast to these high sub-555 
inhibitory concentration scenarios, the exposure to the µg/L levels of QACs present in 556 




This study showed for two selected QACs and two commercial disinfection agents that 559 
P. aeruginosa cells can adapt to these treatments, when exposed to approximately 560 
90% of the MIC. This was exemplified by an increase of the MICs by a maximum factor 561 
of 1.45 for CTMA, 1.9 for BAC, 1.7 for Deconex® 53 PLUS and 1.75 for Incidin® PLUS.  562 
When exposed to a lower concentration (approximately 50% of MIC), strains exposed 563 
to BAC showed a slight adaptation to the product in one replicate. The slight increase 564 
observed upon exposure to 50% of the MIC, may suggest that adaptation is also 565 
possible at smaller concentrations, but longer exposure times are necessary. 566 
Moreover, not only, the MIC for the QAC to which the bacteria were exposed was 567 
increased but also the MIC for the other selected QAC was increased, which means 568 
that there is cross-resistance between the two selected QACs. The increase in the 569 
resistance to the compounds can be a result of an increase of the stiffness as shown 570 
by the AFM results for CTMA. However, the increase in resistance observed when 571 
exposed to BAC, is likely caused by a different mechanism, as no increase in the 572 
stiffness was observed. Differences were also observed in the adhesion properties 573 
following exposure and would require further investigation especially on the biofilm 574 
formation potential after exposure to sub-inhibitory concentrations of QACs. The 575 
roughness, was increased when exposed to both QACs, confirming that QACs are 576 
affecting the membrane and the observed increase might be the consequence of 577 
changes at the inner membrane level. The differences observed in the 578 
nanomechanical properties of the membrane are also consistent with the differences 579 
observed in the resistance evolution following exposure. This may indicate that 580 
different or slightly different mechanisms are involved with the different QACs. In 581 
contrast, no significant change of the QAC pre-treated bacteria was observed 582 
regarding the resistance to antibiotics in this experimental setup based on the EUCAST 583 
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interpretational scheme. This result seems to exclude the spread of antibiotic resistant 584 
P. aeruginosa in the environment following exposure to constant sub-inhibitory 585 
concentrations of QACs. The effects obtained with two commercial disinfections 586 
agents (containing a QAC or glucoprotamin) were similar to results obtained with 587 
QACs.   588 
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Figure 1. Chemical structures of quaternary ammonium compounds. A. Benzalkonium 821 
chloride (BAC); B. Cetyltrimethylammonium chloride (CTMA) 822 






Figure 2. Summary of the experiments performed with P. aeruginosa and the two 825 
QACs. Tubes of MHB with a sub-inhibitory concentration of QAC (either BAC or CTMA) 826 
were inoculated with a pure P. aeruginosa culture. After five and ten exposure cycles, 827 
cross-resistance to the other QAC and to antibiotics was determined. Additionally, after 828 
10 cycles, populations were analyzed by AFM. After exposure to QACs, populations 829 
were sub-cultured for five additional cycles in QAC-free MHB and cross-resistance to 830 





Figure 3. Evolution of the MICs of P. aeruginosa when exposed to sub-inhibitory 834 
concentrations of (A) CTMA (95 mg l-1) or (B) BAC (70 mg l-1). The effect of absence 835 
of the QACs after 10 cycles on the MICs is also shown. Each exposure cycle lasted 48 836 
hours. Each point is the average of at least 4 technical measurements, error bars 837 
represent the standard deviations. A. MIC evolution of three P. aeruginosa populations 838 
exposed to CTMA (CTMA-1/2/3) and one control (not exposed to CTMA) as a function 839 
of the exposure cycles. B. MIC evolution of three  P. aeruginosa populations exposed 840 
to BAC (BAC-1/2/3) and one control (not exposed to BAC) as a function of the 841 
exposure cycles.  842 




Figure 4. Evolution of the P. aeruginosa’s MIC when exposed to (A) Deconex® 53 845 
PLUS or (B) Incidin® PLUS. Three P. aeruginosa populations (exposed to Deconex® 846 
53 PLUS (A) or Incidin® PLUS (B)) and one control (not exposed to Deconex® 53 PLUS 847 
or Incidin® PLUS) as a function of the exposure cycles. Each cycle lasted 24 hours. 848 
Each point is the average of at least 4 technical measurements and error bars 849 
represent the standard deviations. 850 




Figure 5. Correlation factors for the cross-resistance experiment. A. Correlation 853 
between the enhancement factor of the MIC for CTMA and the MIC for BAC when 854 
exposed to CTMA. B. Correlation between the enhancement factor of the MIC for BAC 855 
and the MIC for CTMA when exposed to CTMA. C. Correlation between the 856 
enhancement factor of the MIC for Deconex® 53 PLUS and the MIC for BAC when 857 
exposed to Deconex® 53 PLUS. D. Correlation between the enhancement factor of the 858 





Figure 6. AFM investigation of the mechanical properties of P. aeruginosa. A: 862 
Two representative images are shown for each tested QAC (BAC, middle and CTMA, 863 
right) and one without treatment (ATCC 27583). Below, a typical profile for the outer 864 
membrane roughness (Ra) is plotted as its average value. The Y-axes scales differ 865 
significantly and from left to right are as follows: 250nm, 700nm and 600nm, 866 
respectively. Both treatments with QACs significantly changed the membrane average 867 
roughness as reported in numbers in each plot: 30, 75 and 95 nm, respectively. 868 
Statistical significance was assessed by the Mann-Whitney test and a p-value < 0.05 869 
was considered significant (n=15). B: Adhesion plot distribution. Each dot represents 870 
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a single measured pixel from a bacteria cell. C: Stiffness plot distribution. Each dot 871 
represents a single measured pixel from a bacteria cell. 872 
